As of Oct 06
| -1.60 / -2.82%|
The 15 analysts offering 12-month price forecasts for AbbVie have a median target of 77.00, with a high estimate of 85.00 and a low estimate of 60.00. The median estimate represents a +39.80% increase from the last price of 55.08.
The current consensus among 18 polled investment analysts is to Buy stock in AbbVie. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.